Targeted Treatment in Childhood Epilepsy Syndromes

The mainstay of treatment of epilepsy has been antiepileptic drugs; however, despite the emergence of new agents, a consistent proportion remain drug-resistant. Newer AEDs show promise. However, as it becomes clear that the epilepsies are a group of diseases rather than a single disorder the prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Vezyroglou, Katharina, Cross, J. Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Epilepsy (E Waterhouse, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859845/
https://www.ncbi.nlm.nih.gov/pubmed/27154366
http://dx.doi.org/10.1007/s11940-016-0407-4
_version_ 1782431004369092608
author Vezyroglou, Katharina
Cross, J. Helen
author_facet Vezyroglou, Katharina
Cross, J. Helen
author_sort Vezyroglou, Katharina
collection PubMed
description The mainstay of treatment of epilepsy has been antiepileptic drugs; however, despite the emergence of new agents, a consistent proportion remain drug-resistant. Newer AEDs show promise. However, as it becomes clear that the epilepsies are a group of diseases rather than a single disorder the prospect of targeted treatment in some may become a reality.
format Online
Article
Text
id pubmed-4859845
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-48598452016-05-21 Targeted Treatment in Childhood Epilepsy Syndromes Vezyroglou, Katharina Cross, J. Helen Curr Treat Options Neurol Epilepsy (E Waterhouse, Section Editor) The mainstay of treatment of epilepsy has been antiepileptic drugs; however, despite the emergence of new agents, a consistent proportion remain drug-resistant. Newer AEDs show promise. However, as it becomes clear that the epilepsies are a group of diseases rather than a single disorder the prospect of targeted treatment in some may become a reality. Springer US 2016-05-07 2016 /pmc/articles/PMC4859845/ /pubmed/27154366 http://dx.doi.org/10.1007/s11940-016-0407-4 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Epilepsy (E Waterhouse, Section Editor)
Vezyroglou, Katharina
Cross, J. Helen
Targeted Treatment in Childhood Epilepsy Syndromes
title Targeted Treatment in Childhood Epilepsy Syndromes
title_full Targeted Treatment in Childhood Epilepsy Syndromes
title_fullStr Targeted Treatment in Childhood Epilepsy Syndromes
title_full_unstemmed Targeted Treatment in Childhood Epilepsy Syndromes
title_short Targeted Treatment in Childhood Epilepsy Syndromes
title_sort targeted treatment in childhood epilepsy syndromes
topic Epilepsy (E Waterhouse, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859845/
https://www.ncbi.nlm.nih.gov/pubmed/27154366
http://dx.doi.org/10.1007/s11940-016-0407-4
work_keys_str_mv AT vezyrogloukatharina targetedtreatmentinchildhoodepilepsysyndromes
AT crossjhelen targetedtreatmentinchildhoodepilepsysyndromes

Ejemplares similares